- Country: Ukraine
- Summary: Remdesivir, Lyophilisate for Concentrate for Solution for Infusions, 100 Mg, #6
- UAT Ref No: 91735930
- Deadline: 09 Nov 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: UA-2023-11-06-004266-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description:-Remdesivir, lyophilizate for concentrate for solution for infusions, 100 mg each, No. 6
Type of purchase item:-Products
Purchase specification
Purchase item: Remdesivir, lyophilizate for concentrate for solution for infusions, 100 mg each, No.6
Quantity: 10
Expected value including VAT: 110,000.00UAH
Dates and deadlines
Start date of accepting offers: 06/11/2023 11:17:00
Deadline for submission of tender offers: 09/11/2023 12:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRemdesivir, Lyophilisate for Concentrate for Solution for Infusions, 100 Mg, #6 - Ukraine Tender
The PUBLIC NON-COMMERCIAL ENTERPRISE "CHUDNIVSK HOSPITAL" OF CHUDNIVSK CITY COUNCIL OF ZHYTOMYR REGION, a Government sector organization in Ukraine, has announced a new tender for Remdesivir, Lyophilisate for Concentrate for Solution for Infusions, 100 Mg, #6. This tender is published on UkraineTenders under UAT Ref No: 91735930 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-11-09.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
